Company / SG&A Expense
HARROW, INC. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$152.9M
FY2025
5-year range
$41.3M / $152.9M
FY2021-FY2025
Trend
+18.5%
vs FY2024
Sector context
#90 of 213
Health Care
What the data says
At $153M, HARROW, INC.'s sg&a expense ranks #124 of 213 in the Health Care sector. SG&A Expense has increased for 6 consecutive years, from $29M in FY2019 to $153M in FY2025.
Based on SEC 10-K filings.
$153M in FY2025 with a 5-year CAGR of +37.4%.
Increased from $83M to $153M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +38.0%
- 5-Year CAGR
- +37.4%
- 10-Year CAGR
- -
Sector benchmark
#124 of 213 in Health CareTop 58% of 213This company $152.9M Sector average $722.3M
▼
-78.8% below sector average
Key checks
Key Insights
- HARROW, INC.'s sg&a expense has grown for 6 consecutive years.
- 5-year CAGR of +37.4%, indicating consistent growth.
- In FY2025, sg&a expense increased 18.5% year-over-year.
- Ranks #90 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $152.9M | +18.5% |
| FY2024 | $129.1M | +55.3% |
| FY2023 | $83.1M | +42.7% |
| FY2022 | $58.2M | +41.0% |
| FY2021 | $41.3M | +32.2% |
| FY2020 | $31.2M | +6.9% |
| FY2019 | $29.2M | +0.0% |
| FY2018 | $29.2M | +16.9% |
| FY2017 | $25.0M | +100.1% |
| FY2016 | $12.5M | +54.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026